Deutsche Welle
From DW's "About DW" page: "DW is an unbiased media organization, based in Germany. We provide our journalistic content to people worldwide, giving them the freedom to make up their own minds and the information required to form their own opinions."
Headline Roundup
Type of Content
Approved Story
1
Format
Region
News Item Format
Standard
Image Caption
Plyushkin/Pond5 Images/IMAGO
Autocurated
0
The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision.
"As multiple, variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied," various media outlets quoted the company was quoted as saying.
A document hosted by the EU's European Medicines Agency website confirmed that Vaxzevria was no longer authorized in the region.
In an email to DW, virologist Wolfgang Preiser said "the demand for SARS-CoV-2 vaccines is very low and unlikely to pick up significantly in the foreseeable future, so I understand the reasoning."